Acute ST segment elevation myocardial infarction (STEMI) has a high disability mortality rate, and timely reperfusion treatment can significantly reduce the mortality of patients. Emergency PCI is the preferred strategy for STEMI treatment recommended by domestic and international guidelines. The long-term existence of stents can never completely avoid the formation of thrombosis in the stents and affect the relaxation and contraction of criminal blood vessels. Drug coated balloon provides a new concept and technology of interventional therapy for coronary artery disease in the form of "intervention without implantation". Through balloon dilation of local blood vessels to release anti proliferative drugs to coronary artery wall and inhibit intimal hyperplasia, it can not only treat serious coronary artery disease, improve coronary blood supply and vascular function, but also not leave permanent implants in the blood vessels; The main pathogenesis of STEMI is thrombosis based on the rupture or erosion of coronary atheromatous plaque. In terms of pathophysiological mechanism, drug coated balloons are also suitable for STEMI patients without obvious thrombosis or severe dissection after full pretreatment. The two-dimensional lumen images obtained by traditional coronary angiography can not directly reflect the vessel wall, so we can not evaluate the actual size of the vessel, plaque characteristics and the effect of intervention through coronary angiography; Optical coherence tomography (OCT) uses near-infrared scanning to produce high-resolution tissue microscopic images with a resolution of up to 10 μ m. It can clearly observe the three-layer structure of coronary artery, find abnormal intima structure, and more clearly identify thrombosis, dissection, plaque erosion or collapse in coronary artery, providing more valuable information for optimizing interventional treatment. Therefore, the application of drug coated balloon under the guidance of OCT in STEMI can provide a more accurate and optimized diagnosis and treatment scheme for STEMI patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
300
Drug eluting balloon was used in the experimental group
Drug eluting stent was used in the control group
Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, China
RECRUITINGLate lumen loss rate
Time frame: 10 months after discharge.
Revascularization rate of target lesions
Time frame: 10 months after discharge.
Target vessel revascularization rate
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
Major Adverse Cardiovascular Events
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
Cardiovascular death
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
Recurrent acute myocardial infarction
Time-to-onset for recurrent acute myocardial infarction, as ascertained according to follow-up
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
Stroke
Time-to-onset for stroke, as ascertained according to follow-up
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
All cause of death
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
Unstable angina
Time-to-onset for unstable angina, as ascertained according to follow-up
Time frame: 1 month after discharge, 3 months after discharge, 6 months after discharge, 10 months after discharge.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.